PTC Therapeutics, Inc.
(NASDAQ : PTCT)

( )
PTCT After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
0.66%196.941.3%$565.97m
GILDGilead Sciences, Inc.
0.70%66.420.9%$368.71m
BIIBBiogen Inc.
1.35%238.791.3%$340.32m
ILMNIllumina, Inc.
1.43%309.573.5%$338.07m
ALXNAlexion Pharmaceuticals, Inc.
0.62%106.322.0%$332.28m
CELGCelgene Corporation
0.42%99.371.3%$309.99m
REGNRegeneron Pharmaceuticals, Inc.
3.40%295.872.6%$188.33m
VRTXVertex Pharmaceuticals Incorporated
1.12%178.121.9%$186.01m
AAgilent Technologies, Inc.
-0.18%77.931.6%$185.14m
EXASExact Sciences Corporation
0.55%103.9724.1%$152.91m
SRPTSarepta Therapeutics, Inc.
-3.34%82.5114.6%$139.60m
ACADACADIA Pharmaceuticals Inc.
-2.26%40.7413.9%$129.03m
INCYIncyte Corporation
3.96%81.212.5%$93.98m
ALDRAlder Biopharmaceuticals, Inc.
-0.11%18.6410.2%$81.98m
BMRNBioMarin Pharmaceutical Inc.
-1.38%74.954.3%$76.08m

Company Profile

PTC Therapeutics, Inc. is a biopharmaceutical company, which engages in the discovery and commercialization of clinically-differentiated medicines. It focuses on the development of new treatments for multiple therapeutic areas, including rare diseases and oncology. The company was founded by Allan Steven Jacobson and Stuart W. Peltz on March 31, 1998 and is headquartered in South Plainfield, NJ.